Dr. Mary Smith joined SpringWorks Therapeutics in 2017. She has more than 17 years of experience designing and running clinical development programs across therapeutic areas. Previously, Mary was the Executive Vice President of Gene Therapy at Bamboo Therapeutics, a wholly owned subsidiary of Pfizer, where she led several key gene transfer programs for rare genetic diseases. Prior to joining Bamboo, Mary was Vice President of Product Development at United Therapeutics, with responsibility for biological development in oncology, as well as regenerative medicine and virology. Mary earned a Ph.D. in microbiology/immunology from the University of New Hampshire and received her post-doctoral training at Emory University.